Investment archive

Investment feed — page 20

Back to latest investments

Flashpoint Venture Growth Fund IV closes at $116M

Flashpoint Venture Growth Fund IV closes at $116M

$116M final close, not the $141.5M combined announcement; latter includes a separate $25.5M growth-debt sidecar.

Taravine Partners Fund I holds first close; ~$38M target, amount undisclosed

Taravine Partners Fund I holds first close; ~$38M target, amount undisclosed

Announced first close Nov 5; the issuer's approximately $38M USD equivalent is a future target, NOT money already raised. Four strategic LPs named, their individual commitments undisclosed.

Potential Sciences discloses seed funding and compute; cash proceeds undisclosed

Potential Sciences discloses seed funding and compute; cash proceeds undisclosed

On November 5 Nauta announced an investment in Potential Sciences, led by Sovereign AI Fund and Twin Path Ventures. 'Eight figures' mixes capital with compute resources, so the new cash equity amount cannot be inferred. Nauta Fund VI's first announced portfolio investment.

VÆRIDION closes €30M Series A2 for electric Microliner aircraft

VÆRIDION closes €30M Series A2 for electric Microliner aircraft

The company announced a closed €30M equity Series A2 co-led by SHIFT Invest and Invest-NL on November 5, 2026. Separately, its CAROLUS project was selected for a €94.5M EU Innovation Fund grant, conditional on a grant agreement expected in 2027. The grant is not equity and is excluded from this event's amount.

IA Capital Group announces initial close of Inter-Atlantic Opportunity Fund I

IA Capital Group announces initial close of Inter-Atlantic Opportunity Fund I

IA Capital Group announced its new vehicle's initial (not final) close with QBE Insurance Group as anchor LP. Fintech and insurtech Series B+ primary and secondary investments; fund size and QBE commitment undisclosed.

Nyquis raises $6.3M seed for grid fault monitoring

Nyquis raises $6.3M seed for grid fault monitoring

Issuer-announced seed for Nyquis Node and grid signal analytics.

Alethio Therapeutics announces $90M Series A

Alethio Therapeutics announces $90M Series A

Company-announced $90M Series A; valuation undisclosed.

T-Therapeutics announces $133M Series B led by Advent and British Business Bank

T-Therapeutics announces $133M Series B led by Advent and British Business Bank

Company-announced oversubscribed $133M Series B; valuation undisclosed.

Nooks secures $500M NON-dilutive customer-acquisition funding commitment from General Catalyst CVF

Nooks secures $500M NON-dilutive customer-acquisition funding commitment from General Catalyst CVF

On November 4, 2026 Nooks announced a $500M non-dilutive growth-capital COMMITMENT from General Catalyst's Customer Value Fund to finance customer acquisition. Reuters reported the capital provider participates in returns generated by financed customers, rather than acquiring an ownership stake. Actual disbursements, revenue share and return terms were not disclosed. This is NOT a $500M priced equity round and cannot be added to Nooks' $70M previously reported equity funding.

Finpilot raises $10M Series A led by Lobby Capital

Finpilot raises $10M Series A led by Lobby Capital

Finpilot announced its $10M Series A November 4, 2026, led by Lobby Capital and joined by returning seed backer Madrona. It serves institutional allocators including endowments, pension funds, foundations and hospital investment offices. $10M is new financing; combined disclosed historic financing is approximately $14.5M including 2023 $500K convertible and 2024 $4M seed. Valuation undisclosed.

Pliant raises $80M Series C for B2B payment infrastructure and AI agents

Pliant raises $80M Series C for B2B payment infrastructure and AI agents

Berlin fintech Pliant announced an oversubscribed $80M Series C led by Seaya Nova and Speedinvest, with Illuminate Financial, Motive Partners and Molten Ventures. Company reported ARR above $100M; valuation was not disclosed. Agentic money movement remains subject to product rollout and controls.

Yosemite reports $350M final close for oncology Fund II

Yosemite reports $350M final close for oncology Fund II

$350M total final fund size as confirmed by founder Reed Jobs in a November 4 original interview; January's $200M first close is included and must not be added again. LP commitments by institution, final legal close date and fees are not disclosed.